The STEM-PD trial, an investigational stem cell-based therapy for the treatment of Parkinson’s Disease, has been given regulatory approval for a Phase I/IIa clinical trial.
Source: Lund University | Read the full article at Lund University. |
Läs artikeln på svenska på Lund Universitet.
The STEM-PD Clinical Trial 